Clostridium difficile colitis associated with chronic renal failure

Nephrology Dialysis Transplantation

Volumn 13, Issue 11, 1998, Pages 2842-2846

  Cunney, Robert J ^a,b   Magee, Colm ^a   McNamara, Eleanor ^a   Smyth, Edmond G ^a   Walshe, Joseph ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Antibiotics; Chronic renal failure; Clostridium difficile; Colitis; Uraemia

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; FLUCLOXACILLIN; GLYCOPEPTIDE; MACROLIDE; METRONIDAZOLE; PENICILLIN G; RNA 16S; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CECOSTOMY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; DIARRHEA; FEMALE; FEVER; HUMAN; ILEUS; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TOXIC MEGACOLON;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 0031725591     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.11.2842     Document Type: Article

References (17)

1. Bartlett JG, Chang TW, Gunwith M, Gorbach SL, Onderdonk AB. Antibiotic associated pseudomembranous colitis due to toxin producing clostridia. N Eng J Med 1978; 298: 531 534
2. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Col Rectum 1995; 38: 350 354
3. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the infectious disease society of America. J Infect Dis 1988; 157: 869 876
4. Sturm AW. Rational use of antimicrobial agents and diagnostic microbiology facilities. J Antimicrob Chemother 1988; 22: 257 260
5. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carraige and C. difficile-associated diarrhoea in a cohort of hospitalised patients. J Infect Dis 1990; 162: 678 684
6. Barany P, Stenvinkel P, Nord CE, Bergstrom J. Clostridium difficile infection: a poor prognostic sign in uremic patients? Clin Nephrol 1992; 38: 53 57
7. Prendergast TM, Marini CP, D'Angelo AJ, Sher ME, Cohen JR. Surgical patients with pseudomembranous colitis: factors affecting prognosis. Surgery 1994; 116: 768 774
8. Aubia J, Lloveras J, Munne A et al. Ischaemic colitis in chronic uraemia. Nephron 1981; 29: 146 150
9. Aronsson B, Barany P, Nord CE, Nystrom B, Stenvinkel P. Clostridium difficile-associated diarrhoea in uremic patients. Eur J Clin Microbiol 1987; 6: 352 356
10. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital acquired illness. Am J Surg 1995; 169: 480-483
11. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996; 91: 460-464
12. Fekety R. Antibiotic-associated colitis. In: Mandell GL, Bennett JE. Dolin R, eds. Principles and practice of infectious disease, fourth edition. Churchill Livingstone, New York: 1995; 979-986
13. Triadafilopoulos G, Hallstone AE. Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 1991; 101: 685-691
14. Wilkins E. Trés difficile. J Infect 1993; 26: 1 7
15. Nolan NPM, Kelly CP, Humphreys JFH et al. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut 1987; 28: 1467 1473
16. Langlois S, Pechere JC, Lachance JG. Restrictive antibiotherapy after renal transplantation. CMA Journal 1979; 120: 426-432
17. th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28 October 1, 1997; Toronto, Canada. Abstract J117